Turnstone Biologics Corp. Operating Cash Flow
Turnstone Biologics Corp. reported Operating Cash Flow of -$11.39 million for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2025-08-08
- Turnstone Biologics Corp. net cash provided by (used in) operating activities for the quarter ending 2025-06-30 was -$4.30M.
- Turnstone Biologics Corp. net cash provided by (used in) operating activities for the quarter ending 2025-03-31 was -$7.09M.
- Turnstone Biologics Corp. net cash provided by (used in) operating activities for the quarter ending 2024-12-31 was -$16.48M.
- Turnstone Biologics Corp. net cash provided by (used in) operating activities for the quarter ending 2024-09-30 was -$17.58M.
- Turnstone Biologics Corp. net cash provided by (used in) operating activities for fiscal 2024 was -$67.44M.
- Turnstone Biologics Corp. net cash provided by (used in) operating activities for fiscal 2023 was -$66.15M.
- Turnstone Biologics Corp. net cash provided by (used in) operating activities for fiscal 2022 was -$71.06M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2025-06-30 | -$4.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$11.39M 10-Q · filed 2025-08-08 | -$27.87M derived: sum of 3 quarters · filed 2025-08-08 | -$45.45M derived: sum of 4 quarters · filed 2025-08-08 |
| 2025-03-31 | -$7.09M 10-Q · filed 2025-05-09 | -$23.57M derived: sum of 2 quarters · filed 2025-05-09 | -$41.14M derived: sum of 3 quarters · filed 2025-05-09 | -$57.07M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-12-31 | -$16.48M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$34.05M derived: sum of 2 quarters · filed 2025-03-31 | -$49.98M derived: sum of 3 quarters · filed 2025-08-08 | -$67.44M 10-K · filed 2025-03-31 |
| 2024-09-30 | -$17.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$33.50M derived: sum of 2 quarters · filed 2025-08-08 | -$50.96M 10-Q · filed 2024-11-12 | -$66.47M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-06-30 | -$15.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$33.38M 10-Q · filed 2025-08-08 | -$48.89M derived: sum of 3 quarters · filed 2025-08-08 | -$67.68M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | -$17.46M 10-Q · filed 2025-05-09 | -$32.96M derived: sum of 2 quarters · filed 2025-05-09 | -$51.75M derived: sum of 3 quarters · filed 2025-05-09 | -$66.44M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | -$15.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$34.29M derived: sum of 2 quarters · filed 2025-03-31 | -$48.98M derived: sum of 3 quarters · filed 2025-03-31 | -$66.15M 10-K · filed 2025-03-31 |
| 2023-09-30 | -$18.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$33.48M derived: sum of 2 quarters · filed 2024-11-12 | -$50.65M 10-Q · filed 2024-11-12 | -$70.16M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$14.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$31.86M 10-Q · filed 2024-08-14 | -$51.37M derived: sum of 3 quarters · filed 2024-08-14 | -$63.38M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | -$17.17M 10-Q · filed 2024-05-13 | -$36.68M derived: sum of 2 quarters · filed 2024-05-13 | -$48.69M derived: sum of 3 quarters · filed 2024-05-13 | |
| 2022-12-31 | -$19.51M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | -$31.52M derived: sum of 2 quarters · filed 2024-03-22 | -$71.06M 10-K · filed 2024-03-22 | |
| 2022-09-30 | -$12.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$51.55M 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | -$39.54M 10-Q · filed 2023-09-01 |